Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases

Solid Biosciences Inc. announced a strategic collaboration with Phlox Therapeutics focused on genetic cardiac diseases. The research collaboration targeted a severe form of genetic dilated cardiomyopathy for which there was currently a significant unmet need for effective treatments.